麻豆传媒

The selected channel has been deleted from your list of favorites.
New York, NY USA

Our 麻豆传媒 on 麻豆传媒
View All >

麻豆传媒: 672b9b6a80594_Labdetails-240117-LR-12-RT1200x800.jpg

MSK Research Highlights, November 6, 2024

New MSK research marks a potential advance against RAS-driven cancers; breaks down data silos to better predict cancer outcomes with the help of artificial intelligence (AI); identifies two enzymes vital for maintaining brain health; uncovers how...
6-Nov-2024 11:35 AM EST Add to Favorites

麻豆传媒: 672a6de295087_PetriniJohn-231121-003RTr1200x800.jpg

Ancient Immune Defense System Plays an Unexpected Role in Cancer, MSK Researchers Find

Along with defending against pathogens, the body鈥檚 innate immune system helps to protect the stability of our genomes in unexpected ways 鈥� ways that have important implications for the development of cancer, researchers at MSK are discovering.
5-Nov-2024 2:10 PM EST Add to Favorites

麻豆传媒: 6723d01ce6cbc_MaillardIvan-241030-02-RT-12x8.jpg

Ivan Maillard Named Head of the Division of Hematologic Malignancies at Memorial Sloan Kettering Cancer Center

Ivan Maillard, MD, PhD, has been named Head of the Division of Hematologic Malignancies within the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK).
4-Nov-2024 10:00 AM EST Add to Favorites

麻豆传媒: 67224d9f9f273_ThumbnailImage1200x800.jpg

MSK Awards and Appointments October 2024

NEW YORK, October 31, 2024 鈥� Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:
31-Oct-2024 10:00 AM EDT Add to Favorites

麻豆传媒: 1200x800_StuderSchrag.jpg

Memorial Sloan Kettering Physician-Scientists Elected to the Prestigious National Academy of Medicine

Dr. Deb Schrag, Chair of the Department of Medicine, and Dr. Lorenz Studer, Director of the Center for Stem Cell Biology at Memorial Sloan Kettering Cancer Center (MSK), have been elected to the National Academy of Medicine (NAM), one of the highest...
21-Oct-2024 9:30 AM EDT Add to Favorites

麻豆传媒: 66eaef8877b0f_Xiaolan1200x800.jpg

MSK Research Highlights September 18, 2024

New research from Memorial Sloan Kettering Cancer Center (MSK) uses saturation genome editing to better understanding of the RAD51C gene, which has been linked to higher risks of breast and ovarian cancer; sheds new light on brain metastasis; and...
18-Sep-2024 11:05 AM EDT Add to Favorites

麻豆传媒: 66e1eeeef0b8c_Khaliq1200x8001.jpg

New, Rare Type of Small Cell Lung Cancer Identified by MSK Research Team

A team of doctors and researchers at MSK have identified a new, rare type of small cell lung cancer that primarily affects younger people who have never smoked. Learn how one 19-year-old patient sparked a detective story.
11-Sep-2024 3:05 PM EDT Add to Favorites

麻豆传媒: 66df57dc1541d_awad-mark-240903-hr-06-rt-12x8.jpg

Mark Awad Named Chief of the Thoracic Oncology Service at Memorial Sloan Kettering Cancer Center

Mark Awad, MD, PhD, has been appointed Chief of the Thoracic Oncology Service within the Solid Tumor Oncology Division, Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK).
9-Sep-2024 5:00 PM EDT Add to Favorites


See All News

Our YouTube Videos
View All >

About

The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular purpose:鈥痶o find a cure for鈥痗ancer. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue鈥痮ur mission鈥痑t MSK and around the globe. One of the world鈥檚 most respected comprehensive centers devoted exclusively to cancer, we have been recognized as one of the top two cancer hospitals in the country by U.S. 麻豆传媒 & World Report for more than 30 years. www.mskcc.org鈥��

Twitter

Facebook

close
0.36726